Indegene Ltd's U.S. subsidiary has received preliminary court approval for a class-action settlement related to the Telephone Consumer Protection Act. With a maximum settlement fund of USD 4.72 million, the company noted that actual cash outflow depends on the volume of valid claims filed by December 2026. This move marks a step toward resolving ongoing litigation, with a final hearing scheduled for January 2027.
Indegene Subsidiary Receives Preliminary Settlement Approval in U.S. Litigation
Maximum settlement fund capped at USD 4.72 million; final court hearing scheduled for 12 January 2027.
Reader Takeaway: Preliminary approval advances dispute resolution, though final financial liability remains contingent on actual claim volumes.
What just happened
Indegene Ltd informed the BSE that its wholly-owned subsidiary, Indegene, Inc., has received preliminary approval from the U.S. District Court for the District of New Jersey regarding a class-action lawsuit. The litigation involves allegations under the Telephone Consumer Protection Act (TCPA) of 1991. The court has appointed a dedicated settlement administrator to manage the claims process.
Why this matters
The settlement establishes a framework for resolution, providing clarity on the potential upper limit of financial exposure. By opting for a "claims-made" structure, the company avoids an immediate lump-sum cash outflow. The total fund is set at approximately USD 4.72 million, which acts as a cap rather than a definitive cost. The actual financial impact will be determined by the number of valid claims received and approved, alongside court-sanctioned legal and administrative fees.
Important Timeline
- 10 September 2026: Deadline for providing notice to settlement class members.
- 9 December 2026: Final deadline for potential claimants to submit claims, exclusions, or objections.
- 12 January 2027: Final approval hearing to conclude the matter.
Risks to watch
Investors should note that while this structure limits liability, the litigation remains ongoing until the final approval hearing. The total cost remains variable. There is no requirement for the company to pre-fund or escrow the maximum amount, keeping liquidity intact for now.
What to track next
Shareholders should monitor updates regarding the claims process and the outcome of the January 2027 final approval hearing. Any deviation from the projected settlement framework or legal costs would be a key indicator for future financial reporting.